Effect of AceK (acesulfame potassium) on brain function under dietary restriction in mice. 2018

Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

People preferably take zero or low-calorie beverages and foods with artificial sweeteners even though it has been recently suggested that long-term artificial sweetener use affects physiological functions. In addition, a lower body weight was considered to be more healthful, but an abnormally low body weight caused by an excessive diet has been reported to cause health problems. Acesulfame potassium (AceK) is one of the most commonly used for foods and beverages because of its resistance to thermal degradation and marked sweetness. However, the combined effect of AceK and a low body weight on the physiological functions remains unknown. Here, we investigated the effect of long-term AceK fluid intake on the cognitive function under dietary restriction. We administered AceK to mice fed a low carbohydrate (LC) diet for 4 weeks, and behavioral assays were then performed for a week. The mice fed the LC diet with AceK treatment for 4 weeks showed an increase in water intake and a decrease in short-term and object cognitive memories in the Y-maze and novel object recognition tests, respectively. Mice were sacrificed after behavioral tests to measure glucose levels. The glucose levels in the frontal cortex were significantly decreased in mice fed the LC diet with AceK treatment in comparison with mice fed the LC diet alone, although there was no significant difference in the plasma glucose levels. These results suggest that the combination of long-term AceK intake and the LC diet affects the cognitive function through the reduction of cortical glucose levels.

UI MeSH Term Description Entries
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013549 Sweetening Agents Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) Artificial Sweeteners,Sugar Substitutes,Sweeteners,Agent, Sweetening,Agents, Sweetening,Artificial Sweetener,Substitute, Sugar,Substitutes, Sugar,Sugar Substitute,Sweetener,Sweetener, Artificial,Sweeteners, Artificial,Sweetening Agent

Related Publications

Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
October 2017, Clinical journal of the American Society of Nephrology : CJASN,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
November 2017, Molecular and cellular endocrinology,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
December 2011, Biogerontology,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
September 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
November 1987, Journal of animal science,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
January 2001, Journal of neurochemistry,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
April 1993, Mutation research,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
May 1984, The British journal of nutrition,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
January 1988, The American journal of clinical nutrition,
Daisuke Ibi, and Fumika Suzuki, and Masayuki Hiramatsu
August 2010, Indian journal of biochemistry & biophysics,
Copied contents to your clipboard!